U.S., Feb. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07414043) titled 'Characterization and Phenotyping of Patients Who Are Offered Drug Therapy for Obesity' on Dec. 02, 2025.
Brief Summary: The study is multicenter and observational, consisting of a cross-sectional phase (V0) in which data will be collected from patients who are offered drug therapy, and a prospective longitudinal phase in which only patients who agree to start drug therapy for obesity will be involved
Study Start Date: Oct. 22, 2025
Study Type: OBSERVATIONAL
Condition:
Obesity & Overweight
Recruitment Status: RECRUITING
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
Information provided by (Responsible Party): Ube...